£76.09

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 3 months

Springer Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£76.09 £72.29 £73.81 £75.33 £76.85 £78.37 £79.89 23 August 2026 04 September 2026 16 September 2026 28 September 2026 10 October 2026
View at Amazon ↗

Price data last checked 42 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 49 days • 1 price levels

Days at Price
49 days 0 12 25 37 49 £76 Days at Price

Price Analysis

Most common price: £76 (49 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 49 days

Description

Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called "target" therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy. This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
30 September 2019
Listed Since
30 May 2019

Barcode

No barcode data available

Similar Products You Might Like

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
99% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£71.02 18 Sep 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
98% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£88.68 06 Oct 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£122.54 18 Sep 2026
Malignant Lymphomas & Hodgkin's Disease: Diagnosis Management
97% match

Malignant Lymphomas & Hodgkin's Disease: Diagnosis Management

Springer

£125.20 20 Oct 2026
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
97% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)

Springer

£127.75 30 Oct 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
97% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.67 18 Sep 2026
Lymphoma: Methods and Protocols - Volume 971 Research Guide
97% match

Lymphoma: Methods and Protocols - Volume 971 Research Guide

Humana

£101.40 02 Oct 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£147.34 05 Nov 2026
Springer Atlas of Hematologic Neoplasms - Medical Textbook
97% match

Springer Atlas of Hematologic Neoplasms - Medical Textbook

Springer

£188.80 02 Nov 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£78.01 25 Sep 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
97% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£143.29 29 Oct 2026
Springer Malignant Lymphomas and Hodgkin's Disease Book
96% match

Springer Malignant Lymphomas and Hodgkin's Disease Book

Springer

£395.79 04 Nov 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£422.32 02 Nov 2026
Extranodal Lymphomas: Expert Consult - Online and Print
96% match

Extranodal Lymphomas: Expert Consult - Online and Print

Elsevier

£141.99 20 Oct 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.28 24 Sep 2026
Elsevier Diagnostic Pathology: Lymph Nodes and Lymphomas
96% match

Elsevier Diagnostic Pathology: Lymph Nodes and Lymphomas

Elsevier

£199.75 11 Nov 2026
Lippincott Ioachim's Lymph Node Pathology, 5th Edition
96% match

Lippincott Ioachim's Lymph Node Pathology, 5th Edition

Lippincott Williams & Wilkins

£201.10 26 Sep 2026
Hodgkin's and Non-Hodgkin's Lymphoma: Cancer Treatment Research
96% match

Hodgkin's and Non-Hodgkin's Lymphoma: Cancer Treatment Research

Springer

£46.30 20 Oct 2026
The International Consensus Classification of Myeloid and Lymphoid Neoplasms
96% match

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Lippincott Williams & Wilkins

£106.80 11 Sep 2026
The Peripheral T-Cell Lymphomas
96% match

The Peripheral T-Cell Lymphomas

Wiley

£182.57 04 Nov 2026
Wiley Skin Lymphoma: The Illustrated Guide - Medical Text
96% match

Wiley Skin Lymphoma: The Illustrated Guide - Medical Text

Wiley

£128.73 06 Nov 2026
Rare Lymphomas (Hematologic Malignancies)
96% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£107.55 29 Oct 2026
Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)
96% match

Lymphoma: Methods and Protocols: 2865 (Methods in Molecular Biology, 2865)

Humana

£170.66 23 Oct 2026
Diagnostic Pathology: Blood and Bone Marrow
96% match

Diagnostic Pathology: Blood and Bone Marrow

Elsevier

£186.15 05 Nov 2026